Medicine
27.03.2017, 16:06
Aviva Ventures, Aviva plc’s venture capital arm, today announces its investment in Owlstone Medical Ltd, a medical diagnostics company developing a breathalyser that can detect diseases at a very early stage.
22.03.2017, 15:30
MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs.
22.03.2017, 15:29
Selectively blocking immune cells can prevent formation of scar tissue around medical devices.
22.03.2017, 09:27
Novartis provides update on Phase III study of RLX030 (serelaxin) in patients with acute heart failure
20.03.2017, 15:18
Cytokinetics, Inc. (Nasdaq:CYTK) today announced that additional results from COSMIC-HF, a Phase 2 trial evaluating omecamtiv mecarbil in patients with chronic heart failure, were presented by Tor Biering-Sørensen
16.03.2017, 07:11
Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its oral Janus kinase (JAK) inhibitor, XELJANZ
10.03.2017, 15:32
Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2016
10.03.2017, 09:13
A perinatal centre of Bryansk City Hospital No. 1, which was under the supervision of Governor of the Bryansk region Alexander Bogomaz, began its work on 7 March.
06.03.2017, 16:23
Fitbit today introduced Fitbit Alta HR™ and new advances in sleep tracking, giving you actionable insights and guidance in the Fitbit® app to make more informed decisions about your health and stay motivated to reach your wellness goals in style.
06.03.2017, 15:57
Valeant Completes Approximately $1.1 Billion Pay Down Of Senior Secured Term Loans From Divestitures
Valeant Pharmaceuticals International, Inc. today announced that following the successful closure of the skincare products asset sale on March 3, 2017, Valeant has used the net proceeds of the sale to pay down approximately $1.1 billion of its senior secured term loans
06.03.2017, 10:25
New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine
06.03.2017, 10:23
Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
02.03.2017, 15:26
Edge Therapeutics, Inc. today announced financial results and corporate highlights for the fourth quarter and full-year ended December 31, 2016
02.03.2017, 11:11
On 2 March, an international conference entitled ‘She Decides’ will be held in Brussels. The conference is being co-organised by Sweden, Belgium, the Netherlands and Denmark.
Комментарии